HSIC · Henry Schein, Inc.
$84.952026-07-21Sector: Healthcare; Industry: Medical - Distribution; Sub-Industry: Health Care Distributors
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$17
-80.2% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($17 · $15) Analysts Range ($64 · $100) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $12.3B | — | 5.8% | 21.8% | $559MM | −$1.3B | −$784MM | 7.3% | — | 9.5% | $5.9B | $3.58 | — |
| 2024.Q4 | $12.3B | 0.0% | 5.8% | 24.3% | $540MM | −$225MM | $315MM | 7.9% | — | 9.2% | $5.9B | $3.58 | — |
| 2025.Q1 | $12.7B | 2.7% | 5.8% | 24.1% | $553MM | −$295MM | $258MM | 8.4% | — | 9.2% | $6.2B | $3.36 | — |
| 2025.Q4 | $12.7B | 0.0% | 5.8% | 23.1% | $560MM | −$91MM | $469MM | 7.9% | — | 8.8% | $6.5B | $3.36 | — |
| 2026.Q1 | $13.4B | 5.6% | 5.6% | 23.6% | $572MM | −$205MM | $367MM | 8.0% | — | 8.7% | $6.6B | $3.40 | 13.2 |
| italics below = DCF projection · 10yr Rev CAGR: 3.9% |
| 2027.Q1 | $13.9B | +3.7% | 5.8% | 23.2% | $617MM | −$249MM | $368MM | 7.9% | $341MM | 9.2% | $6.9B | $5.32 | 16.0 |
| 2028.Q1 | $14.4B | +3.8% | 6.2% | 22.9% | $686MM | −$266MM | $420MM | 8.0% | $361MM | 9.8% | $7.1B | $5.91 | 14.4 |
| 2029.Q1 | $14.9B | +3.8% | 6.3% | 22.5% | $733MM | −$283MM | $450MM | 8.1% | $357MM | 10.1% | $7.4B | $6.32 | 13.4 |
| 2030.Q1 | $15.5B | +3.9% | 6.3% | 22.1% | $765MM | −$308MM | $457MM | 8.1% | $336MM | 10.1% | $7.7B | $6.60 | 12.9 |
| 2031.Q1 | $16.2B | +4.0% | 6.3% | 21.8% | $800MM | −$332MM | $467MM | 8.2% | $317MM | 10.1% | $8.1B | $6.89 | 12.3 |
|
| Term. Yr+ | $20.5B | 4.1% | 3.2% | 20.0% | $529MM | −$252MM | $277MM | 8.6% | $2.8B | 8.6% | — | — | — |
Active scenario IV: $17 (-80.2% vs market)